Ambushed Seresto tick collar parent company Elanco to announce first-quarter earnings
Indiana – based Elanco Animal Health Incorporated (NYSE: ELAN) is set to announce its first-quarter earnings this Friday, May 7. A public conference call is also set to take place that morning at 8:00 a.m. eastern time. A live webcast will be accessible via this link, according to the company’s announcement: https://investor.elanco.com/events-and-presentations/default.aspx.
Exactly one year ago, Elanco CEO Jeffrey Simmons presented the company’s 2020 first-quarter earnings, which included results for just acquired Bayer Animal Health – – and Seresto flea and tick collars. According to a transcript of the call, CEO Simmons began with a discussion of how the company has been able to expand the geographic distribution of Galliprant, one of the newer non-steroidal anti-inflammatory drugs (NSAIDs) developed to treat osteoarthritis.
Seresto, the flea and tick prevention collars at the center of a news media controversy, grew 51% in Q1’s first quarter. It will, of course, be interesting to see what those numbers are now this Friday.
“Seresto grew 51% and Advantage grew 10.5%,” CEO Simmons said last year during the earnings call, “with both products showing the strongest sales gains in the U.S.”